ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript March 3, 2025
ADMA Biologics, Inc. misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.15.
Operator: Good afternoon and welcome to the ADMA Biologics Fourth Quarter and Full Year 2024 Financial Results and Business Update Conference Call on Monday, March 3rd, 2025. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised...
